1. Home
  2. FOFO vs KPTI Comparison

FOFO vs KPTI Comparison

Compare FOFO & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOFO
  • KPTI
  • Stock Information
  • Founded
  • FOFO 2017
  • KPTI 2008
  • Country
  • FOFO Hong Kong
  • KPTI United States
  • Employees
  • FOFO N/A
  • KPTI N/A
  • Industry
  • FOFO
  • KPTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOFO
  • KPTI Health Care
  • Exchange
  • FOFO Nasdaq
  • KPTI Nasdaq
  • Market Cap
  • FOFO 112.0M
  • KPTI 102.4M
  • IPO Year
  • FOFO 2025
  • KPTI 2013
  • Fundamental
  • Price
  • FOFO $9.93
  • KPTI $5.34
  • Analyst Decision
  • FOFO
  • KPTI Strong Buy
  • Analyst Count
  • FOFO 0
  • KPTI 7
  • Target Price
  • FOFO N/A
  • KPTI $29.71
  • AVG Volume (30 Days)
  • FOFO 106.9K
  • KPTI 178.4K
  • Earning Date
  • FOFO 01-01-0001
  • KPTI 11-03-2025
  • Dividend Yield
  • FOFO N/A
  • KPTI N/A
  • EPS Growth
  • FOFO N/A
  • KPTI N/A
  • EPS
  • FOFO 0.36
  • KPTI N/A
  • Revenue
  • FOFO $3,117,608.00
  • KPTI $142,530,000.00
  • Revenue This Year
  • FOFO N/A
  • KPTI $4.87
  • Revenue Next Year
  • FOFO N/A
  • KPTI $9.20
  • P/E Ratio
  • FOFO $32.37
  • KPTI N/A
  • Revenue Growth
  • FOFO 1597.65
  • KPTI N/A
  • 52 Week Low
  • FOFO $4.63
  • KPTI $3.51
  • 52 Week High
  • FOFO $68.00
  • KPTI $14.24
  • Technical
  • Relative Strength Index (RSI)
  • FOFO N/A
  • KPTI 38.19
  • Support Level
  • FOFO N/A
  • KPTI $6.09
  • Resistance Level
  • FOFO N/A
  • KPTI $6.17
  • Average True Range (ATR)
  • FOFO 0.00
  • KPTI 0.44
  • MACD
  • FOFO 0.00
  • KPTI -0.09
  • Stochastic Oscillator
  • FOFO 0.00
  • KPTI 6.76

About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: